NEUROPHARMACOLOGY impact factor, indexing, ranking (2024)


NEUROPHARMACOLOGY

Aim and Scope

The NEUROPHARMACOLOGY is a research journal that publishes research related to Neuroscience; Pharmacology, Toxicology and Pharmaceutics. This journal is published by the Elsevier Ltd.. The ISSN of this journal is 00283908, 18737064. Based on the Scopus data, the SCImago Journal Rank (SJR) of NEUROPHARMACOLOGY is 1.307.

Also, please check the following important details about NEUROPHARMACOLOGY: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

NEUROPHARMACOLOGY Ranking

Impact Factor: 5.273
Total Citations: 28216
SJR (SCImago Journal Rank): 1.307
Quartile: Q1

The Impact Factor of NEUROPHARMACOLOGY is 5.273.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.


Important Metrics

Journal Title: Neuropharmacology
Publisher: Elsevier Ltd.
ISSN: 00283908, 18737064
Type: journal
Journal Scope: Neuroscience; Pharmacology, Toxicology and Pharmaceutics
Country: United Kingdom
H-Index: 184
SJR: 1.307
Quartile: Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2)

NEUROPHARMACOLOGY Indexing

The NEUROPHARMACOLOGY is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


NEUROPHARMACOLOGY Impact Factor 2024

The latest impact factor of NEUROPHARMACOLOGY is 5.273.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.


NEUROPHARMACOLOGY Quartile

The latest Quartile of NEUROPHARMACOLOGY is Q1.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in NEUROPHARMACOLOGY?

If your research is related to Neuroscience; Pharmacology, Toxicology and Pharmaceutics, then visit the official website of NEUROPHARMACOLOGY and send your manuscript.

Tips for publishing in NEUROPHARMACOLOGY:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Journal Publication Time

The publication time may vary depending on factors such as the complexity of the research and the current workload of the editorial team. Journals typically request reviewers to submit their reviews within 3-4 weeks. However, some journals lack mechanisms to enforce this deadline, making it difficult to predict the duration of the peer review process.

The review time also depends upon the quality of the research paper.


Final Summary

  • The impact factor of NEUROPHARMACOLOGY is 5.273.
  • The NEUROPHARMACOLOGY is a reputed research journal.
  • It is published by Elsevier Ltd..
  • The journal is indexed in UGC CARE, Scopus, SCIE, PubMed.
  • The (SJR) SCImago Journal Rank is 1.307.

Sources: NEUROPHARMACOLOGY







Similiar Journals


ALCOHOL
ISSN: 0741-8329
Publisher: ELSEVIER SCIENCE INC

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
ISSN: 0362-1642
Publisher: ANNUAL REVIEWS

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
ISSN: 1742-7835
Publisher: WILEY

BMC PHARMACOLOGY & TOXICOLOGY
ISSN:
Publisher: BMC

CHEMICO-BIOLOGICAL INTERACTIONS
ISSN: 0009-2797
Publisher: ELSEVIER IRELAND LTD

DRUG AND CHEMICAL TOXICOLOGY
ISSN: 0148-0545
Publisher: TAYLOR & FRANCIS LTD

DRUGS
ISSN: 0012-6667
Publisher: ADIS INT LTD

DRUG SAFETY
ISSN: 0114-5916
Publisher: ADIS INT LTD

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
ISSN: 1382-6689
Publisher: ELSEVIER

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
ISSN: 1742-5255
Publisher: TAYLOR & FRANCIS LTD

Top 20 Journals

Credit and Source: Scopus, Clarivate, UGC CARE.